ACETAMINOPHEN, ASPRIN, CAFFEINE

ACETAMINOPHEN, ASPRIN, CAFFEINE was reported 7229 times

ACETAMINOPHEN, ASPRIN, CAFFEINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INTRACRANIAL VENOUS SINUS STENOSIS 7 0.3889
1 MEDICATION OVERUSE HEADACHE 148 0.1729
2 BLOOD CAFFEINE INCREASED 4 0.0714
3 POSTNATAL GROWTH RESTRICTION 9 0.0687
4 DRUG EFFECT VARIABLE 50 0.0441
5 OPTIC DISC HAEMORRHAGE 7 0.0306
6 EMERGENCY CARE EXAMINATION 17 0.0251
7 LARYNGITIS FUNGAL 3 0.0233
8 THUNDERCLAP HEADACHE 6 0.0229
9 BLOOD ZINC DECREASED 4 0.0220
10 NONREASSURING FOETAL HEART RATE PATTERN 3 0.0135
11 LABELLED DRUG-FOOD INTERACTION MEDICATION ERROR 6 0.0120
12 BLOOD VISCOSITY DECREASED 4 0.0119
13 ADHESIVE TAPE USE 4 0.0104
14 DRUG WITHDRAWAL HEADACHE 4 0.0096
15 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 18 0.0091
16 HEMIPLEGIC MIGRAINE 3 0.0088
17 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 8 0.0075
18 MEDICAL DEVICE SITE PAIN 4 0.0071
19 ULCER HAEMORRHAGE 48 0.0071
20 PRODUCT USED FOR UNKNOWN INDICATION 6 0.0048
21 GESTATIONAL HYPERTENSION 6 0.0046
22 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 133 0.0045
23 GASTRIC PERFORATION 12 0.0044
24 REBOUND ACID HYPERSECRETION 13 0.0043
25 OBSTRUCTION GASTRIC 5 0.0039
26 ESSENTIAL HYPERTENSION 7 0.0038
27 AORTIC DILATATION 4 0.0036
28 IDIOPATHIC INTRACRANIAL HYPERTENSION 8 0.0036
29 ANOGENITAL WARTS 3 0.0034
30 GASTRIC OPERATION 3 0.0033
31 ULCER 52 0.0033
32 GASTRIC ULCER PERFORATION 4 0.0032
33 NEPHROGENIC ANAEMIA 14 0.0030
34 DRUG EFFECT DELAYED 13 0.0029
35 THERAPEUTIC PRODUCT EFFECT VARIABLE 11 0.0028
36 ALLERGY TO ANIMAL 3 0.0028
37 EPIGASTRIC DISCOMFORT 11 0.0028
38 MIGRAINE 267 0.0028
39 TRAUMATIC HAEMATOMA 3 0.0028
40 HYPERCOAGULATION 5 0.0026
41 PELVIC ABSCESS 3 0.0026
42 GASTRIC ULCER HAEMORRHAGE 14 0.0025
43 HYPERPARATHYROIDISM SECONDARY 6 0.0024
44 GASTRITIS EROSIVE 11 0.0024
45 CALCIUM DEFICIENCY 3 0.0023
46 OTORRHOEA 4 0.0023
47 GASTRIC DISORDER 77 0.0022
48 LYMPHOCYTE PERCENTAGE DECREASED 3 0.0022
49 PRODUCT TAMPERING 4 0.0022
50 GASTRIC ULCER 42 0.0022
51 FEELING JITTERY 42 0.0022
52 CLUSTER HEADACHE 3 0.0022
53 INFUSION SITE RASH 3 0.0022
54 GASTRIC HAEMORRHAGE 25 0.0022
55 FAT TISSUE INCREASED 3 0.0021
56 PAPILLOEDEMA 9 0.0020
57 DEVICE RELATED SEPSIS 4 0.0020
58 THERAPEUTIC RESPONSE UNEXPECTED 89 0.0020
59 TORTICOLLIS 4 0.0019
60 MIGRAINE WITH AURA 5 0.0018
61 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 13 0.0018
62 GASTROINTESTINAL ULCER 4 0.0018
63 PRODUCT PACKAGE ASSOCIATED INJURY 4 0.0018
64 MENINGITIS ASEPTIC 8 0.0018
65 HYPERURICAEMIA 7 0.0017
66 END STAGE RENAL DISEASE 31 0.0017
67 BLOOD HIV RNA INCREASED 3 0.0017
68 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 11 0.0016
69 LYMPH NODE PAIN 3 0.0016
70 AURA 3 0.0016
71 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 3 0.0016
72 PARANASAL SINUS DISCOMFORT 6 0.0016
73 HYPOREFLEXIA 3 0.0016
74 OESOPHAGEAL ULCER 6 0.0016
75 OESOPHAGEAL DISORDER 6 0.0016
76 CONTRAINDICATED PRODUCT ADMINISTERED 47 0.0016
77 ATROPHY 3 0.0015
78 THERAPEUTIC PRODUCT EFFECT DELAYED 7 0.0015
79 DRUG INEFFECTIVE 2019 0.0015
80 PNEUMONIA STAPHYLOCOCCAL 3 0.0015
81 DRUG EFFECT INCOMPLETE 55 0.0015
82 WEIGHT BEARING DIFFICULTY 4 0.0015
83 HEPATIC CYST 5 0.0015
84 GESTATIONAL DIABETES 7 0.0015
85 DRUG ADMINISTRATION ERROR 45 0.0015
86 CLUMSINESS 4 0.0015
87 CHRONIC KIDNEY DISEASE 111 0.0015
88 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 80 0.0015
89 DRUG SCREEN FALSE POSITIVE 4 0.0014
90 VITAMIN D DEFICIENCY 14 0.0014
91 LIVE BIRTH 12 0.0014
92 INCORRECT DOSAGE ADMINISTERED 7 0.0014
93 APPLICATION SITE BURN 7 0.0014
94 FIBULA FRACTURE 4 0.0014
95 PRODUCT PHYSICAL ISSUE 28 0.0014
96 MIDDLE EAR EFFUSION 3 0.0014
97 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 12 0.0014
98 SNORING 5 0.0013
99 BOWEL MOVEMENT IRREGULARITY 10 0.0013
100 POOR QUALITY SLEEP 28 0.0013
101 FORMICATION 9 0.0013
102 FAMILY STRESS 4 0.0013
103 ANAL INCONTINENCE 11 0.0012
104 SPRUE-LIKE ENTEROPATHY 6 0.0012
105 DRUG EFFECT LESS THAN EXPECTED 18 0.0012
106 FEELING DRUNK 9 0.0012
107 CATHETER SITE HAEMORRHAGE 3 0.0012
108 ERECTION INCREASED 5 0.0012
109 DRUG TOLERANCE 6 0.0012
110 TOOTH FRACTURE 13 0.0012
111 ANGLE CLOSURE GLAUCOMA 3 0.0012
112 HORDEOLUM 5 0.0012
113 DRUG SCREEN POSITIVE 9 0.0011
114 SCOLIOSIS 7 0.0011
115 ANIMAL BITE 3 0.0011
116 BLEPHAROSPASM 7 0.0011
117 PHOTOPSIA 7 0.0011
118 PRODUCT QUALITY ISSUE 149 0.0011
119 PLEURITIC PAIN 3 0.0011
120 DENTAL CARIES 12 0.0011
121 HYPERACUSIS 4 0.0011
122 INITIAL INSOMNIA 11 0.0011
123 ANAL HAEMORRHAGE 3 0.0011
124 PRODUCT USE IN UNAPPROVED INDICATION 265 0.0011
125 TUBULOINTERSTITIAL NEPHRITIS 20 0.0011
126 INCORRECT DRUG ADMINISTRATION DURATION 30 0.0011
127 SOMNAMBULISM 7 0.0011
128 CHRONIC SINUSITIS 4 0.0011
129 MATERNAL EXPOSURE TIMING UNSPECIFIED 4 0.0011
130 SEASONAL ALLERGY 15 0.0011
131 IMPAIRED DRIVING ABILITY 12 0.0011
132 MICTURITION URGENCY 12 0.0010
133 SPEECH DISORDER DEVELOPMENTAL 3 0.0010
134 PHARYNGEAL DISORDER 3 0.0010
135 PARAPLEGIA 3 0.0010
136 PULMONARY PAIN 3 0.0010
137 AUTONOMIC NERVOUS SYSTEM IMBALANCE 3 0.0010
138 URINE ODOUR ABNORMAL 6 0.0010
139 DECREASED INTEREST 6 0.0010
140 ABDOMINAL DISCOMFORT 170 0.0010
141 SINUS DISORDER 20 0.0010
142 BLADDER DISORDER 10 0.0010
143 ACNE CYSTIC 3 0.0010
144 BRAIN NEOPLASM 9 0.0010
145 PRE-EXISTING CONDITION IMPROVED 6 0.0010
146 INTENTIONAL UNDERDOSE 7 0.0010
147 INFUSION SITE PRURITUS 3 0.0009
148 CEREBRAL DISORDER 7 0.0009
149 BLADDER PAIN 3 0.0009
150 OVERWEIGHT 5 0.0009
151 PRODUCT RESIDUE PRESENT 5 0.0009
152 BLOOD MAGNESIUM DECREASED 8 0.0009
153 HYDROCEPHALUS 5 0.0009
154 DISSOCIATION 7 0.0009
155 HAEMORRHAGIC ANAEMIA 4 0.0009
156 GASTROINTESTINAL PAIN 10 0.0009
157 NEAR DEATH EXPERIENCE 3 0.0009
158 ABDOMINAL PAIN UPPER 187 0.0009
159 DYSMENORRHOEA 12 0.0009
160 PEPTIC ULCER 3 0.0009
161 OVARIAN CYST 9 0.0009
162 POST-TRAUMATIC STRESS DISORDER 6 0.0009
163 EUPHORIC MOOD 9 0.0009
164 HEADACHE 548 0.0009
165 INCREASED TENDENCY TO BRUISE 8 0.0009
166 SYNOVIAL CYST 4 0.0009
167 TACHYPHRENIA 3 0.0009
168 HYPOAESTHESIA ORAL 13 0.0009
169 HYPERREFLEXIA 3 0.0009
170 TRANSFUSION 9 0.0009
171 CAROTID ARTERY STENOSIS 3 0.0009
172 UMBILICAL HERNIA 4 0.0009
173 THROMBOPHLEBITIS 3 0.0009
174 HANGOVER 3 0.0009
175 TIBIA FRACTURE 4 0.0009
176 LACERATION 8 0.0008
177 SKIN TIGHTNESS 4 0.0008
178 APPARENT DEATH 3 0.0008
179 PARAESTHESIA ORAL 12 0.0008
180 SPONDYLITIS 3 0.0008
181 TENSION 5 0.0008
182 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 58 0.0008
183 PAIN IN JAW 23 0.0008
184 LIMB INJURY 22 0.0008
185 MUSCLE TIGHTNESS 13 0.0008
186 BLOOD CALCIUM INCREASED 7 0.0008
187 PHOTOPHOBIA 15 0.0008
188 SPINAL OSTEOARTHRITIS 7 0.0008
189 HEPATIC NECROSIS 3 0.0008
190 FACE INJURY 3 0.0008
191 EXTRA DOSE ADMINISTERED 32 0.0008
192 LIVER DISORDER 35 0.0008
193 INTENTIONAL PRODUCT MISUSE 69 0.0008
194 PARANASAL SINUS HYPERSECRETION 3 0.0008
195 TINNITUS 36 0.0008
196 TOOTHACHE 14 0.0008
197 MALABSORPTION 4 0.0008
198 INSOMNIA 204 0.0008
199 PRODUCT ADMINISTRATION INTERRUPTED 6 0.0008
200 PARTIAL SEIZURES 4 0.0008
201 SKIN ODOUR ABNORMAL 3 0.0008
202 DYSPEPSIA 75 0.0008
203 PRODUCT USE COMPLAINT 12 0.0008
204 DYSGRAPHIA 5 0.0008
205 DRUG DEPENDENCE 122 0.0008
206 SUSPECTED COUNTERFEIT PRODUCT 3 0.0008
207 WALKING AID USER 5 0.0008
208 RENAL CYST 6 0.0008
209 FOREIGN BODY 3 0.0007
210 QUALITY OF LIFE DECREASED 10 0.0007
211 FUNGAL SKIN INFECTION 3 0.0007
212 RENAL INJURY 22 0.0007
213 ERYTHEMA OF EYELID 4 0.0007
214 HYPERSOMNIA 21 0.0007
215 INTERVERTEBRAL DISC PROTRUSION 16 0.0007
216 SPINAL OPERATION 9 0.0007
217 NONSPECIFIC REACTION 4 0.0007
218 THYROID FUNCTION TEST ABNORMAL 3 0.0007
219 PRODUCT COMPLAINT 18 0.0007
220 PREMATURE LABOUR 4 0.0007
221 UTERINE HAEMORRHAGE 3 0.0007
222 PRODUCT DISPENSING ISSUE 3 0.0007
223 INFUSION SITE PAIN 9 0.0007
224 TENSION HEADACHE 3 0.0007
225 HIATUS HERNIA 9 0.0007
226 TOOTH INJURY 3 0.0007
227 SCIATICA 11 0.0007
228 SKIN WARM 4 0.0007
229 MELANOCYTIC NAEVUS 3 0.0007
230 DYSPHEMIA 3 0.0007
231 UTERINE LEIOMYOMA 5 0.0007
232 ONYCHOMYCOSIS 3 0.0007
233 FEELING OF BODY TEMPERATURE CHANGE 4 0.0007
234 ENERGY INCREASED 4 0.0007
235 PRODUCT SUBSTITUTION ISSUE 39 0.0007
236 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 48 0.0007
237 TOOTH DISORDER 15 0.0007
238 FACIAL PAIN 6 0.0007
239 TENDERNESS 7 0.0007
240 GASTROOESOPHAGEAL REFLUX DISEASE 54 0.0007
241 MACULAR DEGENERATION 8 0.0007
242 EAR PAIN 13 0.0007
243 PRODUCT ODOUR ABNORMAL 7 0.0007
244 IRON DEFICIENCY 3 0.0007
245 INCONTINENCE 7 0.0007
246 RESTLESS LEGS SYNDROME 12 0.0007
247 ILL-DEFINED DISORDER 40 0.0007
248 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 4 0.0007
249 PALPITATIONS 77 0.0007
250 EXOSTOSIS 6 0.0007
251 EAR DISORDER 3 0.0007
252 RENAL FAILURE 87 0.0007
253 HEREDITARY ANGIOEDEMA 7 0.0007
254 LIVER INJURY 16 0.0007
255 LOCALISED OEDEMA 3 0.0006
256 ARTHRITIS INFECTIVE 3 0.0006
257 INCORRECT PRODUCT ADMINISTRATION DURATION 14 0.0006
258 NECK PAIN 36 0.0006
259 NEPHROPATHY 6 0.0006
260 INFUSION SITE SWELLING 4 0.0006
261 SKIN ABRASION 3 0.0006
262 SPINAL DISORDER 6 0.0006
263 FOOT FRACTURE 12 0.0006
264 PRE-ECLAMPSIA 3 0.0006
265 GAIT INABILITY 21 0.0006
266 CYSTITIS 20 0.0006
267 HUMERUS FRACTURE 3 0.0006
268 ATELECTASIS 6 0.0006
269 REBOUND EFFECT 7 0.0006
270 MUSCLE DISORDER 5 0.0006
271 ABNORMAL DREAMS 17 0.0006
272 BACK DISORDER 10 0.0006
273 DERMATITIS CONTACT 7 0.0006
274 GOUT 11 0.0006
275 KIDNEY INFECTION 12 0.0006
276 IMPAIRED WORK ABILITY 13 0.0006
277 GASTRITIS 16 0.0006
278 LIVER FUNCTION TEST INCREASED 13 0.0006
279 GASTROINTESTINAL SOUNDS ABNORMAL 3 0.0006
280 PANIC ATTACK 22 0.0006
281 CONTUSION 58 0.0006
282 EXPIRED PRODUCT ADMINISTERED 20 0.0006
283 MULTIPLE SCLEROSIS RELAPSE 41 0.0006
284 ATRIAL SEPTAL DEFECT 5 0.0006
285 BREAST MASS 4 0.0006
286 INFUSION SITE ERYTHEMA 5 0.0006
287 UTERINE PERFORATION 5 0.0006
288 THINKING ABNORMAL 11 0.0006
289 BLOOD IRON DECREASED 7 0.0006
290 INSURANCE ISSUE 9 0.0006
291 PRODUCT COLOUR ISSUE 3 0.0006
292 HOT FLUSH 44 0.0006
293 ECCHYMOSIS 4 0.0006
294 PERIPHERAL COLDNESS 8 0.0006
295 CENTRAL NERVOUS SYSTEM LESION 8 0.0006
296 LIMB DISCOMFORT 18 0.0006
297 TEMPERATURE INTOLERANCE 6 0.0006
298 FEELING ABNORMAL 139 0.0006
299 TOOTH LOSS 12 0.0006
300 LARGE INTESTINE POLYP 4 0.0006
301 LARGE INTESTINE PERFORATION 4 0.0006
302 FIBROMYALGIA 14 0.0006
303 NERVOUSNESS 30 0.0006
304 EXTRASYSTOLES 4 0.0006
305 RIGHT VENTRICULAR FAILURE 4 0.0006
306 PAPULE 4 0.0006
307 IMMUNOSUPPRESSION 5 0.0006
308 PRODUCT COMMUNICATION ISSUE 5 0.0006
309 RENAL PAIN 6 0.0006
310 HAND FRACTURE 4 0.0006
311 ANORECTAL DISCOMFORT 3 0.0006
312 CHOKING 11 0.0006
313 BREAST PAIN 6 0.0006
314 ANXIETY 160 0.0006
315 GASTROINTESTINAL MOTILITY DISORDER 3 0.0006
316 VERTIGO 34 0.0006
317 GASTROINTESTINAL INFECTION 5 0.0006
318 DRUG EFFECT DECREASED 30 0.0006
319 GINGIVITIS 3 0.0006
320 CHEILITIS 3 0.0006
321 MENSTRUATION DELAYED 6 0.0006
322 VISUAL FIELD DEFECT 4 0.0006
323 BONE PAIN 32 0.0005
324 ORAL DISORDER 4 0.0005
325 ROTATOR CUFF SYNDROME 7 0.0005
326 PRODUCT ADMINISTRATION ERROR 11 0.0005
327 CHOKING SENSATION 3 0.0005
328 HYPERKERATOSIS 3 0.0005
329 BALANCE DISORDER 47 0.0005
330 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 110 0.0005
331 PRODUCT USE ISSUE 102 0.0005
332 BLINDNESS TRANSIENT 4 0.0005
333 NERVE COMPRESSION 5 0.0005
334 IRON DEFICIENCY ANAEMIA 5 0.0005
335 INTERVERTEBRAL DISC DEGENERATION 5 0.0005
336 MEDICATION ERROR 30 0.0005
337 MEMORY IMPAIRMENT 74 0.0005
338 INTERMENSTRUAL BLEEDING 3 0.0005
339 SUNBURN 4 0.0005
340 HYPOAESTHESIA 80 0.0005
341 JOINT STIFFNESS 14 0.0005
342 CHROMATURIA 12 0.0005
343 TOOTH INFECTION 7 0.0005
344 SINUSITIS 54 0.0005
345 HEART RATE INCREASED 52 0.0005
346 SLEEP APNOEA SYNDROME 10 0.0005
347 MUSCULOSKELETAL DISCOMFORT 9 0.0005
348 HERPES VIRUS INFECTION 3 0.0005
349 PHARYNGEAL OEDEMA 8 0.0005
350 HYPERVENTILATION 3 0.0005
351 MUSCULOSKELETAL CHEST PAIN 8 0.0005
352 RETCHING 11 0.0005
353 EXPOSURE DURING PREGNANCY 32 0.0005
354 DYSSTASIA 15 0.0005
355 IMPAIRED GASTRIC EMPTYING 7 0.0005
356 AUTOIMMUNE DISORDER 5 0.0005
357 HAEMORRHOIDS 10 0.0005
358 NAUSEA 405 0.0005
359 MULTIPLE ALLERGIES 4 0.0005
360 RENAL TUBULAR NECROSIS 5 0.0005
361 LYMPHOCYTE COUNT DECREASED 9 0.0005
362 THERAPY CHANGE 5 0.0005
363 HEAD DISCOMFORT 9 0.0005
364 OROPHARYNGEAL PAIN 47 0.0005
365 FAECES DISCOLOURED 11 0.0005
366 GLUCOSE TOLERANCE IMPAIRED 3 0.0005
367 TREMOR 84 0.0005
368 SINUS HEADACHE 3 0.0005
369 ORAL DISCOMFORT 7 0.0005
370 BACK PAIN 117 0.0005
371 TRICUSPID VALVE INCOMPETENCE 4 0.0005
372 COORDINATION ABNORMAL 7 0.0005
373 WRIST FRACTURE 6 0.0005
374 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 24 0.0005
375 INCORRECT DOSE ADMINISTERED 114 0.0005
376 BLOOD PRESSURE INADEQUATELY CONTROLLED 3 0.0005
377 SPEECH DISORDER 26 0.0005
378 RHINITIS 4 0.0005
379 CONSTIPATION 108 0.0005
380 FRUSTRATION TOLERANCE DECREASED 4 0.0005
381 FLATULENCE 28 0.0005
382 RENAL DISORDER 23 0.0005
383 EYELID PTOSIS 5 0.0005
384 MUSCULOSKELETAL STIFFNESS 43 0.0005
385 MOTOR DYSFUNCTION 5 0.0005
386 PARAESTHESIA 77 0.0005
387 EAR INFECTION 13 0.0005
388 SMALL INTESTINAL OBSTRUCTION 6 0.0005
389 EAR DISCOMFORT 5 0.0005
390 RIB FRACTURE 10 0.0005
391 CONCOMITANT DISEASE AGGRAVATED 3 0.0005
392 ILLNESS 50 0.0005
393 SWELLING FACE 31 0.0005
394 BRAIN OEDEMA 6 0.0005
395 PRODUCT DOSE OMISSION 31 0.0005
396 HEAD INJURY 15 0.0005
397 JOINT DISLOCATION 5 0.0005
398 URINARY INCONTINENCE 14 0.0005
399 ACUTE KIDNEY INJURY 72 0.0005
400 DEPRESSION 107 0.0005
401 VITAMIN D DECREASED 4 0.0005
402 CRYING 17 0.0005
403 SCAR 8 0.0005
404 BLOOD POTASSIUM DECREASED 14 0.0005
405 CARDIAC OPERATION 4 0.0005
406 CARDIAC FLUTTER 3 0.0005
407 INJECTION SITE BRUISING 37 0.0005
408 POOR QUALITY DRUG ADMINISTERED 3 0.0005
409 DECREASED ACTIVITY 5 0.0005
410 MYOPATHY 4 0.0005
411 PRURITUS GENERALISED 10 0.0005
412 MUSCLE STRAIN 4 0.0005
413 HEPATITIS ACUTE 3 0.0005
414 FATIGUE 359 0.0005
415 PLATELET COUNT INCREASED 6 0.0005
416 BIPOLAR DISORDER 5 0.0005
417 GAIT DISTURBANCE 88 0.0005
418 BACK INJURY 5 0.0005
419 NEPHROLITHIASIS 21 0.0005
420 NAIL DISORDER 4 0.0005
421 BEDRIDDEN 6 0.0005
422 ADVERSE EVENT 42 0.0005
423 ACTIVITIES OF DAILY LIVING IMPAIRED 9 0.0005
424 WITHDRAWAL SYNDROME 19 0.0005
425 EYE HAEMORRHAGE 6 0.0004
426 INFLUENZA LIKE ILLNESS 37 0.0004
427 MALIGNANT MELANOMA 6 0.0004
428 AMNESIA 29 0.0004
429 OCULAR DISCOMFORT 5 0.0004
430 DIZZINESS 222 0.0004
431 DISTURBANCE IN ATTENTION 24 0.0004
432 ARTHRITIS 35 0.0004
433 ANGER 15 0.0004
434 PSORIATIC ARTHROPATHY 18 0.0004
435 PRODUCT LABEL ISSUE 3 0.0004
436 SOMNOLENCE 89 0.0004
437 ABNORMAL LOSS OF WEIGHT 3 0.0004
438 MOOD SWINGS 14 0.0004
439 MULTIPLE SCLEROSIS 21 0.0004
440 MATERNAL EXPOSURE BEFORE PREGNANCY 3 0.0004
441 ACUTE HEPATIC FAILURE 6 0.0004
442 DEPRESSED MOOD 23 0.0004
443 HAEMATEMESIS 11 0.0004
444 LYMPHOEDEMA 3 0.0004
445 FEELING COLD 12 0.0004
446 MUSCLE SPASMS 79 0.0004
447 EYE SWELLING 16 0.0004
448 APHONIA 6 0.0004
449 HEPATIC STEATOSIS 8 0.0004
450 HEPATIC ENCEPHALOPATHY 4 0.0004
451 THERAPY CESSATION 22 0.0004
452 CHOLELITHIASIS 14 0.0004
453 CHEST PAIN 79 0.0004
454 IMPAIRED HEALING 14 0.0004
455 DUODENAL ULCER 3 0.0004
456 BLOOD PRESSURE INCREASED 65 0.0004
457 PRODUCT DOSE OMISSION IN ERROR 12 0.0004
458 ADVERSE DRUG REACTION 38 0.0004
459 DIVERTICULUM 3 0.0004
460 DYSPHAGIA 40 0.0004
461 JOINT INJURY 9 0.0004
462 VOMITING 198 0.0004
463 COAGULOPATHY 7 0.0004
464 IRRITABLE BOWEL SYNDROME 9 0.0004
465 APPLICATION SITE ERYTHEMA 11 0.0004
466 CEREBRAL HAEMORRHAGE 15 0.0004
467 CHILLS 49 0.0004
468 UPPER GASTROINTESTINAL HAEMORRHAGE 7 0.0004
469 PERIPHERAL SWELLING 64 0.0004
470 GLAUCOMA 8 0.0004
471 HEPATITIS C 5 0.0004
472 HERNIA 8 0.0004
473 BURNING SENSATION 29 0.0004
474 SKIN DISCOLOURATION 19 0.0004
475 HEMIPARESIS 7 0.0004
476 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 7 0.0004
477 RASH PUSTULAR 3 0.0004
478 NOCTURIA 5 0.0004
479 APATHY 6 0.0004
480 MAJOR DEPRESSION 3 0.0004
481 DYSPHONIA 24 0.0004
482 NO THERAPEUTIC RESPONSE 5 0.0004
483 PHARYNGEAL SWELLING 4 0.0004
484 COELIAC DISEASE 4 0.0004
485 POLLAKIURIA 17 0.0004
486 MENORRHAGIA 8 0.0004
487 HYPOTHYROIDISM 13 0.0004
488 HEPATOMEGALY 4 0.0004
489 COGNITIVE DISORDER 19 0.0004
490 SENSITIVE SKIN 3 0.0004
491 LOSS OF CONSCIOUSNESS 52 0.0004
492 NIGHT SWEATS 13 0.0004
493 MOOD ALTERED 11 0.0004
494 CYST 5 0.0004
495 INABILITY TO AFFORD MEDICATION 4 0.0004
496 TOOTH EXTRACTION 5 0.0004
497 UPPER LIMB FRACTURE 8 0.0004
498 MUSCULOSKELETAL PAIN 21 0.0004
499 HYDRONEPHROSIS 3 0.0004
500 RASH MACULAR 14 0.0004
501 MALAISE 175 0.0004
502 BRAIN INJURY 4 0.0004
503 OVERDOSE 86 0.0004
504 PAROSMIA 3 0.0004
505 APHASIA 12 0.0004
506 UNDERDOSE 29 0.0004
507 MUSCLE ATROPHY 5 0.0004
508 FEEDING DISORDER 8 0.0004
509 STAPHYLOCOCCAL INFECTION 13 0.0004
510 TOOTH ABSCESS 4 0.0004
511 CHEST DISCOMFORT 40 0.0004
512 FUNGAL INFECTION 13 0.0004
513 SEIZURE 45 0.0004
514 THYROID DISORDER 6 0.0004
515 EMOTIONAL DISORDER 12 0.0004
516 MYALGIA 66 0.0004
517 EYE PRURITUS 13 0.0004
518 EYE DISCHARGE 4 0.0004
519 BASAL CELL CARCINOMA 6 0.0004
520 BONE DISORDER 7 0.0004
521 ROAD TRAFFIC ACCIDENT 16 0.0004
522 FALL 127 0.0004
523 PAIN IN EXTREMITY 112 0.0004
524 GASTROINTESTINAL DISORDER 34 0.0004
525 DRUG ADMINISTERED AT INAPPROPRIATE SITE 4 0.0004
526 THROAT IRRITATION 17 0.0004
527 PNEUMOTHORAX 6 0.0004
528 ADVERSE REACTION 5 0.0004
529 GINGIVAL PAIN 3 0.0004
530 ABSCESS 6 0.0004
531 NIGHTMARE 13 0.0004
532 MIDDLE INSOMNIA 7 0.0004
533 BODY HEIGHT DECREASED 4 0.0004
534 SENSORY DISTURBANCE 6 0.0004
535 HAIR TEXTURE ABNORMAL 5 0.0004
536 INJECTION SITE PRURITUS 25 0.0004
537 LABORATORY TEST ABNORMAL 11 0.0004
538 SENSORY LOSS 3 0.0004
539 EYE PAIN 21 0.0004
540 PAIN 227 0.0004
541 PRODUCT TASTE ABNORMAL 5 0.0004
542 POST PROCEDURAL INFECTION 3 0.0004
543 BLOOD URINE PRESENT 7 0.0004
544 SLEEP DISORDER 26 0.0004
545 DECUBITUS ULCER 3 0.0004
546 PULMONARY THROMBOSIS 4 0.0004
547 GINGIVAL BLEEDING 5 0.0004
548 ABNORMAL FAECES 3 0.0004
549 HYPERAESTHESIA 3 0.0004
550 LETHARGY 21 0.0004
551 BLOOD GLUCOSE FLUCTUATION 4 0.0004
552 BRONCHITIS 27 0.0004
553 ESCHERICHIA INFECTION 3 0.0004
554 SKIN LESION 10 0.0004
555 DRUG PRESCRIBING ERROR 7 0.0004
556 HAIR DISORDER 3 0.0004
557 FLUSHING 37 0.0004
558 ACUTE RESPIRATORY FAILURE 7 0.0004
559 DYSGEUSIA 27 0.0004
560 INJECTION SITE ERYTHEMA 45 0.0004
561 HAEMATOCHEZIA 20 0.0004
562 THERAPEUTIC RESPONSE SHORTENED 12 0.0004
563 ERUCTATION 7 0.0004
564 VISUAL ACUITY REDUCED 12 0.0004
565 DIVERTICULITIS 10 0.0004
566 LIP SWELLING 12 0.0004
567 NERVE INJURY 4 0.0004
568 URINARY RETENTION 12 0.0004
569 HYPOMAGNESAEMIA 5 0.0004
570 GASTROINTESTINAL HAEMORRHAGE 30 0.0004
571 FEELING HOT 22 0.0004
572 ORAL PAIN 8 0.0004
573 VISION BLURRED 49 0.0004
574 THERAPY NON-RESPONDER 16 0.0004
575 INTENTIONAL PRODUCT USE ISSUE 31 0.0004
576 OSTEOARTHRITIS 15 0.0004
577 URTICARIA 59 0.0004
578 SCAB 4 0.0004
579 RED BLOOD CELL COUNT DECREASED 10 0.0003
580 PARALYSIS 5 0.0003
581 FULL BLOOD COUNT DECREASED 7 0.0003
582 MUSCLE TWITCHING 8 0.0003
583 HYSTERECTOMY 3 0.0003
584 VAGINAL HAEMORRHAGE 15 0.0003
585 MENTAL DISORDER 15 0.0003
586 COMPLICATION ASSOCIATED WITH DEVICE 5 0.0003
587 CAESAREAN SECTION 4 0.0003
588 GROIN PAIN 3 0.0003
589 ARTHRALGIA 142 0.0003
590 SPLENOMEGALY 4 0.0003
591 GRIP STRENGTH DECREASED 3 0.0003
592 SKIN HAEMORRHAGE 5 0.0003
593 ATAXIA 4 0.0003
594 CHOLECYSTITIS 4 0.0003
595 THROMBOSIS 27 0.0003
596 CONDITION AGGRAVATED 102 0.0003
597 ABDOMINAL DISTENSION 35 0.0003
598 HYPERLIPIDAEMIA 4 0.0003
599 FEAR 9 0.0003
600 MOBILITY DECREASED 24 0.0003
601 THROAT TIGHTNESS 9 0.0003
602 DRUG DOSE OMISSION 55 0.0003
603 GASTROENTERITIS VIRAL 6 0.0003
604 INFLUENZA 37 0.0003
605 HALLUCINATION 25 0.0003
606 HALLUCINATION, VISUAL 7 0.0003
607 OSTEOMYELITIS 6 0.0003
608 PELVIC PAIN 6 0.0003
609 DEHYDRATION 44 0.0003
610 SKIN DISORDER 11 0.0003
611 BLOOD COUNT ABNORMAL 5 0.0003
612 ADRENAL INSUFFICIENCY 4 0.0003
613 OSTEOPENIA 5 0.0003
614 EATING DISORDER 7 0.0003
615 BLOOD THYROID STIMULATING HORMONE INCREASED 3 0.0003
616 DYSURIA 12 0.0003
617 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 11 0.0003
618 MUSCULAR WEAKNESS 37 0.0003
619 HAEMORRHAGE 34 0.0003
620 UROSEPSIS 3 0.0003
621 SKIN CANCER 7 0.0003
622 MENTAL STATUS CHANGES 9 0.0003
623 PERSONALITY CHANGE 3 0.0003
624 TENDONITIS 5 0.0003
625 VISUAL IMPAIRMENT 40 0.0003
626 WOUND 9 0.0003
627 ILEUS 4 0.0003
628 EJECTION FRACTION DECREASED 5 0.0003
629 HAIR COLOUR CHANGES 4 0.0003
630 APPENDICITIS 3 0.0003
631 ALOPECIA 63 0.0003
632 DIARRHOEA 207 0.0003
633 THERAPY PARTIAL RESPONDER 5 0.0003
634 DRY MOUTH 26 0.0003
635 FLANK PAIN 3 0.0003
636 CATARACT 19 0.0003
637 ARTERIOSCLEROSIS 3 0.0003
638 DECREASED APPETITE 74 0.0003
639 ASTHMA 36 0.0003
640 INTESTINAL OBSTRUCTION 12 0.0003
641 CELLULITIS 16 0.0003
642 URINARY TRACT INFECTION 54 0.0003
643 ABDOMINAL PAIN LOWER 8 0.0003
644 HEPATOTOXICITY 7 0.0003
645 INCREASED APPETITE 6 0.0003
646 GLOSSODYNIA 7 0.0003
647 POST PROCEDURAL COMPLICATION 6 0.0003
648 AFFECT LABILITY 3 0.0003
649 ASTHENIA 117 0.0003
650 HEART RATE IRREGULAR 7 0.0003
651 RHINORRHOEA 20 0.0003
652 NASOPHARYNGITIS 57 0.0003
653 PRODUCT ADHESION ISSUE 11 0.0003
654 RESPIRATORY TRACT INFECTION 8 0.0003
655 NASAL CONGESTION 18 0.0003
656 DEAFNESS 8 0.0003
657 BODY TEMPERATURE DECREASED 3 0.0003
658 PSYCHOTIC DISORDER 9 0.0003
659 METASTASES TO BONE 5 0.0003
660 HOSPICE CARE 3 0.0003
661 DISABILITY 6 0.0003
662 ACNE 23 0.0003
663 MATERNAL EXPOSURE DURING PREGNANCY 27 0.0003
664 HAEMATOCRIT DECREASED 6 0.0003
665 C-REACTIVE PROTEIN INCREASED 11 0.0003
666 GENERALISED TONIC-CLONIC SEIZURE 5 0.0003
667 DIABETES MELLITUS 23 0.0003
668 ACCIDENTAL OVERDOSE 11 0.0003
669 SALIVARY HYPERSECRETION 3 0.0003
670 SWELLING 28 0.0003
671 HYPERTENSION 63 0.0003
672 STOMATITIS 18 0.0003
673 VAGINAL DISCHARGE 3 0.0003
674 CANDIDA INFECTION 5 0.0003
675 HERPES ZOSTER 17 0.0003
676 SUICIDAL IDEATION 27 0.0003
677 DRUG LEVEL DECREASED 3 0.0003
678 PULMONARY EMBOLISM 28 0.0003
679 NEUROPATHY PERIPHERAL 28 0.0003
680 SLUGGISHNESS 3 0.0003
681 BODY TEMPERATURE INCREASED 6 0.0003
682 DYSPNOEA EXERTIONAL 11 0.0003
683 PSORIASIS 38 0.0003
684 HYPERSENSITIVITY 54 0.0003
685 APPLICATION SITE RASH 4 0.0003
686 WEIGHT DECREASED 81 0.0003
687 POOR VENOUS ACCESS 3 0.0003
688 COUGH 81 0.0003
689 PROCEDURAL PAIN 8 0.0003
690 PRESYNCOPE 7 0.0003
691 PETECHIAE 3 0.0003
692 HYPERHIDROSIS 37 0.0003
693 HUNGER 4 0.0003
694 LOCAL SWELLING 5 0.0003
695 MASS 4 0.0003
696 FOLLICULITIS 3 0.0003
697 WEIGHT INCREASED 64 0.0003
698 CARPAL TUNNEL SYNDROME 4 0.0003
699 AMENORRHOEA 5 0.0003
700 BLOOD TEST ABNORMAL 4 0.0003
701 INJURY 20 0.0003
702 SCRATCH 3 0.0003
703 FULL BLOOD COUNT ABNORMAL 3 0.0003
704 IRRITABILITY 17 0.0003
705 LYMPHADENOPATHY 10 0.0003
706 UPPER RESPIRATORY TRACT INFECTION 13 0.0003
707 EPISTAXIS 21 0.0003
708 AGEUSIA 7 0.0003
709 MOVEMENT DISORDER 9 0.0003
710 GALLBLADDER DISORDER 5 0.0003
711 ABDOMINAL PAIN 65 0.0003
712 IMPAIRED QUALITY OF LIFE 4 0.0003
713 CEREBROVASCULAR ACCIDENT 47 0.0003
714 RASH PRURITIC 15 0.0003
715 GASTROENTERITIS 4 0.0003
716 RESTLESSNESS 10 0.0003
717 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 5 0.0003
718 HAEMOGLOBIN DECREASED 28 0.0003
719 UNRESPONSIVE TO STIMULI 7 0.0003
720 FOOT DEFORMITY 3 0.0003
721 BLINDNESS 11 0.0003
722 SYNCOPE 27 0.0003
723 PHARMACEUTICAL PRODUCT COMPLAINT 7 0.0003
724 DIPLOPIA 7 0.0003
725 COLON CANCER 4 0.0003
726 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 14 0.0003
727 RASH PAPULAR 6 0.0003
728 TYPE 2 DIABETES MELLITUS 9 0.0003
729 TRANSIENT ISCHAEMIC ATTACK 9 0.0003
730 BONE LOSS 4 0.0003
731 EYE INFECTION 3 0.0003
732 PRURITUS 102 0.0003
733 HEPATIC FAILURE 8 0.0003
734 HEPATIC ENZYME INCREASED 18 0.0003
735 ECONOMIC PROBLEM 4 0.0003
736 COLITIS 10 0.0003
737 ASPARTATE AMINOTRANSFERASE INCREASED 14 0.0003
738 CHOLECYSTECTOMY 3 0.0003
739 INTERNAL HAEMORRHAGE 3 0.0003
740 DEEP VEIN THROMBOSIS 17 0.0003
741 MENSTRUATION IRREGULAR 7 0.0003
742 NEOPLASM 3 0.0003
743 DEVICE RELATED INFECTION 4 0.0003
744 DRUG INTOLERANCE 25 0.0003
745 MADAROSIS 3 0.0003
746 PRESCRIBED OVERDOSE 5 0.0003
747 FEMUR FRACTURE 8 0.0003
748 WHITE BLOOD CELL COUNT DECREASED 28 0.0003
749 OEDEMA 14 0.0003
750 ERYTHEMA 53 0.0003
751 DEVICE DIFFICULT TO USE 17 0.0003
752 JOINT SWELLING 31 0.0003
753 DEVICE MALFUNCTION 18 0.0003
754 BRAIN FOG 4 0.0003
755 DEVICE DISLOCATION 11 0.0003
756 DYSPNOEA 143 0.0003
757 BLOOD PRESSURE ABNORMAL 5 0.0003
758 UNEVALUABLE EVENT 19 0.0003
759 HAEMOPTYSIS 7 0.0003
760 PRESCRIBED UNDERDOSE 5 0.0003
761 DEMENTIA 7 0.0003
762 PREGNANCY 5 0.0002
763 SPINAL FRACTURE 5 0.0002
764 INJECTION SITE SWELLING 19 0.0002
765 INJECTION SITE PAIN 76 0.0002
766 MENTAL IMPAIRMENT 6 0.0002
767 FOETAL EXPOSURE DURING PREGNANCY 20 0.0002
768 DISCOMFORT 15 0.0002
769 THERAPEUTIC PRODUCT EFFECT DECREASED 11 0.0002
770 INJECTION SITE URTICARIA 6 0.0002
771 MULTIPLE FRACTURES 4 0.0002
772 EYE DISORDER 8 0.0002
773 OSTEOPOROSIS 10 0.0002
774 INJECTION SITE WARMTH 5 0.0002
775 TENDON RUPTURE 3 0.0002
776 HYPERCALCAEMIA 3 0.0002
777 ABASIA 6 0.0002
778 LOWER RESPIRATORY TRACT INFECTION 11 0.0002
779 BLOOD ALKALINE PHOSPHATASE INCREASED 6 0.0002
780 ANAEMIA 46 0.0002
781 LIVER FUNCTION TEST ABNORMAL 7 0.0002
782 PULMONARY HYPERTENSION 5 0.0002
783 RHEUMATOID ARTHRITIS 27 0.0002
784 SKIN BURNING SENSATION 17 0.0002
785 MOUTH ULCERATION 5 0.0002
786 ATRIAL FIBRILLATION 23 0.0002
787 INJECTION SITE IRRITATION 3 0.0002
788 CONFUSIONAL STATE 38 0.0002
789 HYPOPHAGIA 6 0.0002
790 PRODUCT DOSE OMISSION ISSUE 69 0.0002
791 METRORRHAGIA 4 0.0002
792 ARTHROPATHY 13 0.0002
793 RECTAL HAEMORRHAGE 10 0.0002
794 SKIN ULCER 6 0.0002
795 PARANOIA 4 0.0002
796 LACRIMATION INCREASED 7 0.0002
797 HAEMATOMA 6 0.0002
798 BLISTER 13 0.0002
799 INJECTION SITE INDURATION 3 0.0002
800 CORONARY ARTERY DISEASE 7 0.0002
801 NODULE 3 0.0002
802 EPILEPSY 7 0.0002
803 ANHEDONIA 6 0.0002
804 INJECTION SITE RASH 7 0.0002
805 ANKYLOSING SPONDYLITIS 3 0.0002
806 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 41 0.0002
807 APPLICATION SITE PAIN 5 0.0002
808 CARDIAC DISORDER 21 0.0002
809 SWOLLEN TONGUE 7 0.0002
810 THIRST 4 0.0002
811 JAUNDICE 6 0.0002
812 OEDEMA PERIPHERAL 27 0.0002
813 LEUKOCYTOSIS 4 0.0002
814 APPLICATION SITE PRURITUS 5 0.0002
815 PRODUCT AVAILABILITY ISSUE 5 0.0002
816 WHEEZING 13 0.0002
817 INTENTIONAL OVERDOSE 14 0.0002
818 INJECTION SITE REACTION 15 0.0002
819 PROSTATIC SPECIFIC ANTIGEN INCREASED 3 0.0002
820 INJECTION SITE MASS 8 0.0002
821 FLUID RETENTION 11 0.0002
822 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 5 0.0002
823 DEVICE OCCLUSION 3 0.0002
824 BLINDNESS UNILATERAL 3 0.0002
825 DYSARTHRIA 8 0.0002
826 COVID-19 37 0.0002
827 OCULAR HYPERAEMIA 10 0.0002
828 VIRAL INFECTION 7 0.0002
829 MUSCULOSKELETAL DISORDER 4 0.0002
830 PRODUCTIVE COUGH 10 0.0002
831 RASH ERYTHEMATOUS 10 0.0002
832 HYPOACUSIS 9 0.0002
833 BLOOD PRESSURE FLUCTUATION 5 0.0002
834 LOWER LIMB FRACTURE 4 0.0002
835 LOCALISED INFECTION 5 0.0002
836 HYPOKINESIA 3 0.0002
837 RASH 90 0.0002
838 PLATELET COUNT DECREASED 22 0.0002
839 RESPIRATORY FAILURE 15 0.0002
840 NEURALGIA 5 0.0002
841 PRODUCT STORAGE ERROR 18 0.0002
842 DRUG WITHDRAWAL SYNDROME 18 0.0002
843 BLOOD PRESSURE SYSTOLIC INCREASED 4 0.0002
844 ORAL HERPES 4 0.0002
845 HAEMATURIA 7 0.0002
846 IMMUNODEFICIENCY 3 0.0002
847 HAEMORRHAGE INTRACRANIAL 3 0.0002
848 INJECTION SITE HAEMORRHAGE 16 0.0002
849 HEART RATE DECREASED 7 0.0002
850 CARDIAC FAILURE CONGESTIVE 16 0.0002
851 INTENTIONAL SELF-INJURY 4 0.0002
852 BONE MARROW FAILURE 4 0.0002
853 PYREXIA 68 0.0002
854 INFUSION RELATED REACTION 13 0.0002
855 THERAPY INTERRUPTED 14 0.0002
856 NEOPLASM MALIGNANT 13 0.0002
857 ANKLE FRACTURE 3 0.0002
858 RASH GENERALISED 5 0.0002
859 DRUG DOSE OMISSION BY DEVICE 15 0.0002
860 INTENTIONAL DRUG MISUSE 4 0.0002
861 SEDATION 5 0.0002
862 CYANOSIS 3 0.0002
863 AGITATION 14 0.0002
864 HALLUCINATION, AUDITORY 3 0.0002
865 HOSPITALISATION 29 0.0002
866 OBESITY 3 0.0002
867 HIP FRACTURE 6 0.0002
868 INFECTION 27 0.0002
869 PRODUCT PRESCRIBING ISSUE 4 0.0002
870 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
871 TREATMENT NONCOMPLIANCE 10 0.0002
872 ALANINE AMINOTRANSFERASE INCREASED 11 0.0002
873 PULMONARY OEDEMA 8 0.0002
874 SNEEZING 4 0.0002
875 PANCREATITIS ACUTE 4 0.0002
876 FACE OEDEMA 3 0.0002
877 SKIN EXFOLIATION 15 0.0002
878 TARDIVE DYSKINESIA 5 0.0002
879 DISORIENTATION 7 0.0002
880 ANGINA PECTORIS 5 0.0002
881 INFLAMMATION 9 0.0002
882 PERICARDIAL EFFUSION 4 0.0002
883 DEVICE USE ISSUE 3 0.0002
884 EOSINOPHILIA 3 0.0002
885 COLD SWEAT 3 0.0002
886 TREATMENT FAILURE 14 0.0002
887 TACHYCARDIA 15 0.0002
888 DISEASE RECURRENCE 8 0.0002
889 ISCHAEMIC STROKE 3 0.0002
890 PRODUCT PRESCRIBING ERROR 4 0.0002
891 BLOOD PRESSURE DECREASED 11 0.0002
892 THERAPEUTIC RESPONSE DECREASED 10 0.0002
893 DRY SKIN 22 0.0002
894 PNEUMONIA 53 0.0002
895 OFF LABEL USE 143 0.0002
896 BLOOD GLUCOSE ABNORMAL 3 0.0002
897 BACTERIAL INFECTION 3 0.0002
898 DRY EYE 8 0.0002
899 DRUG-INDUCED LIVER INJURY 5 0.0002
900 BLOOD SODIUM DECREASED 3 0.0002
901 PULMONARY FIBROSIS 3 0.0002
902 HEPATITIS 4 0.0002
903 ERECTILE DYSFUNCTION 4 0.0002
904 DRUG RESISTANCE 4 0.0002
905 ACCIDENTAL EXPOSURE TO PRODUCT 16 0.0002
906 RENAL IMPAIRMENT 13 0.0002
907 DYSTONIA 3 0.0002
908 HYPOTENSION 31 0.0002
909 SKIN FISSURES 3 0.0002
910 HYPOKALAEMIA 7 0.0002
911 DRUG INTERACTION 24 0.0002
912 BLOOD CHOLESTEROL INCREASED 7 0.0002
913 ABORTION SPONTANEOUS 6 0.0001
914 PAIN OF SKIN 4 0.0001
915 TASTE DISORDER 3 0.0001
916 DYSKINESIA 6 0.0001
917 COMA 7 0.0001
918 PALLOR 4 0.0001
919 GENERAL PHYSICAL HEALTH DETERIORATION 17 0.0001
920 BLOOD GLUCOSE DECREASED 7 0.0001
921 DISEASE PROGRESSION 17 0.0001
922 MYOCARDIAL INFARCTION 25 0.0001
923 DERMATITIS 3 0.0001
924 INCORRECT ROUTE OF DRUG ADMINISTRATION 5 0.0001
925 WRONG TECHNIQUE IN DRUG USAGE PROCESS 5 0.0001
926 SURGERY 8 0.0001
927 MELAENA 3 0.0001
928 COLITIS ULCERATIVE 6 0.0001
929 EMOTIONAL DISTRESS 16 0.0001
930 PLEURAL EFFUSION 8 0.0001
931 SKIN IRRITATION 6 0.0001
932 ARRHYTHMIA 6 0.0001
933 ANAPHYLACTIC REACTION 7 0.0001
934 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
935 METABOLIC ACIDOSIS 4 0.0001
936 CEREBRAL INFARCTION 3 0.0001
937 LUNG DISORDER 6 0.0001
938 EYE IRRITATION 7 0.0001
939 OSTEONECROSIS OF JAW 3 0.0001
940 RHABDOMYOLYSIS 5 0.0001
941 AGGRESSION 6 0.0001
942 GASTRIC CANCER 3 0.0001
943 BLOOD GLUCOSE INCREASED 22 0.0001
944 SUICIDE ATTEMPT 7 0.0001
945 DEVICE LEAKAGE 5 0.0001
946 INCORRECT DOSE ADMINISTERED BY DEVICE 3 0.0001
947 SYSTEMIC LUPUS ERYTHEMATOSUS 4 0.0001
948 PNEUMONITIS 3 0.0001
949 HYPERGLYCAEMIA 4 0.0001
950 DEPENDENCE 6 0.0001
951 RESPIRATORY DISTRESS 3 0.0001
952 SEPSIS 12 0.0001
953 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 5 0.0001
954 INTENTIONAL DOSE OMISSION 3 0.0001
955 NEEDLE ISSUE 3 0.0001
956 ABNORMAL BEHAVIOUR 4 0.0001
957 DEVICE ISSUE 9 0.0001
958 RESPIRATORY DISORDER 3 0.0001
959 PREMATURE BABY 3 0.0001
960 NEUTROPHIL COUNT DECREASED 4 0.0001
961 NERVOUS SYSTEM DISORDER 3 0.0001
962 BONE DENSITY DECREASED 3 0.0001
963 DERMATITIS ATOPIC 5 0.0001
964 PANCREATITIS 5 0.0001
965 RENAL FAILURE ACUTE 4 0.0001
966 ANGIOEDEMA 4 0.0001
967 OXYGEN SATURATION DECREASED 5 0.0001
968 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
969 NEUTROPENIA 11 0.0001
970 MALIGNANT NEOPLASM PROGRESSION 8 0.0001
971 PLASMA CELL MYELOMA 3 0.0001
972 ECZEMA 4 0.0001
973 BRADYCARDIA 4 0.0001
974 CARDIAC FAILURE 6 0.0001
975 SEPTIC SHOCK 3 0.0001
976 THROMBOCYTOPENIA 7 0.0001
977 HYPOGLYCAEMIA 3 0.0001
978 DEVICE EXPULSION 4 0.0001
979 BLOOD CREATININE INCREASED 4 0.0001
980 DRUG ABUSE 5 0.0001
981 DEATH 49 0.0001
982 PANCYTOPENIA 3 0.0001
983 CONVULSION 3 0.0001
984 CARDIAC ARREST 4 0.0000
985 TOXICITY TO VARIOUS AGENTS 8 0.0000
986 BREAST CANCER 4 0.0000
987 PROSTATE CANCER 3 0.0000
988 NO ADVERSE EVENT 6 0.0000